Successful Delivery After Planned Discontinuation of Imatinib in a Patient With Chronic Myeloid Leukemia

Internal Medicine - Japan
doi 10.2169/internalmedicine.48.1687
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine